4.7 Article

Basic Fibroblast Growth Factor Attenuates Injury in Myocardial Infarction by Enhancing Hypoxia-Inducible Factor-1 Alpha Accumulation

Journal

FRONTIERS IN PHARMACOLOGY
Volume 11, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2020.01193

Keywords

hypoxia-inducible factor-1 alpha; basic fibroblast growth factor (FGF2); ischemic cardiomyopathy; angiogenesis; antiapoptosis

Funding

  1. National Natural Science Foundation of China [81570299, 81570238, 81570342, 81870281]
  2. Technology Plan Project of Zhejiang Province [WKJ-ZJ-1725]
  3. Foundation ofWenzhou science and technology bureau [Y20160027]

Ask authors/readers for more resources

Background The combination of antiapoptotic and angiogenic actions may represent a pharmacotherapeutic strategy for the treatment of myocardial infarction. Fibroblast growth factor (FGF) is expressed in various cell types including endothelial and muscle cells and promotes their survival, migration, and proliferation. Methods and Results Myocardial microvascular endothelial cells were divided into four treatment groups, the sham, hypoxia, basic FGF (bFGF), and bFGF plus 2-methoxyestradiol groups, and subjected toin vitroapoptotic analysis and Matrigel assays. Anin vivomodel of myocardial infarction was established by ligaturing the left coronary artery of mice in the four treatment groups. Cardiac performance, myocardial injury, endothelial cell angiogenesis, and myocardial apoptosis were assessed. bFGF administration after myocardial infarction improved cardiac function and cell viability, attenuated myocardial injury and apoptosis, and enhanced angiogenesis. Western blotting of HIF-1 alpha, p-AKT, VEGF, p53, BAX, and Bcl-2 showed that bFGF increased HIF-1 alpha, p-AKT, VEGF, and Bcl-2 and decreased BAX protein levels. Conclusion The results of the present study indicated that bFGF attenuates myocardial injury by inhibiting apoptosis and promoting angiogenesisviaa novel HIF-1 alpha-mediated mechanism and a potential utility of bFGF in protecting against myocardial infarction.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available